Literature DB >> 12502916

Atrial fibrillation in the elderly.

Anil Yadav1, Melvin Scheinman.   

Abstract

Atrial fibrillation is the most common arrhythmia in the United States, whose incidence is greatest in the elderly population. This rhythm disorder can be paroxysmal or chronic and is associated with a range of clinical conditions from palpitations and dyspnea to stroke and death. In the elderly the mainstay of treatment of atrial fibrillation should utilize drug therapy. The main goals of drug therapy should be effective rate control to avoid tachycardia-induced cardiomyopathy, anticoagulation to reduce the risk of stroke and thromboembolism, and maintenance of sinus rhythm to prevent adverse atrial remodeling. In those patients in whom effective rate control cannot be achieved, catheter ablation of the atrioventricular node and implantation of a permanent pacemaker should be considered. Catheter ablation of atrial fibrillation by targeting pulmonary venous foci or pulmonary venous isolation currently remains investigational and we advocate its use be limited to symptomatic patients who have failed traditional therapy. Copyright 2003 CVRR, Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12502916     DOI: 10.1111/j.1076-7460.2003.01754.x

Source DB:  PubMed          Journal:  Am J Geriatr Cardiol        ISSN: 1076-7460


  1 in total

Review 1.  Pharmacologic management of atrial fibrillation in the elderly: rate control, rhythm control, and anticoagulation.

Authors:  Seth McClennen; Peter J Zimetbaum
Journal:  Curr Cardiol Rep       Date:  2003-09       Impact factor: 2.931

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.